Cargando…
What are the clinical benefits of tocilizumab for COVID-19 patients? Evidence from available case-control studies
Autores principales: | Ghazvini, Kiarash, Karbalaei, Mohsen, Keikha, Masoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657604/ http://dx.doi.org/10.1016/j.phclin.2020.11.003 |
Ejemplares similares
-
Clinical efficacy of vitamin D supplementation on pulmonary TB patients: The evidence of clinical trials
por: Karbalaei, Mohsen, et al.
Publicado: (2020) -
Third booster vaccination and stopping the Omicron, a new variant of concern
por: Ghazvini, Kiarash, et al.
Publicado: (2022) -
Third booster vaccination and stopping the Omicron, a new variant of concern
por: Ghazvini, Kiarash, et al.
Publicado: (2022) -
Comment on “nontuberculous mycobacterial infection after lung transplantation: a report of four cases”
por: Keikha, Masoud, et al.
Publicado: (2019) -
SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)